| Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs E Galia, E Nicolaides, D Hörter, R Löbenberg, C Reppas, JB Dressman Pharmaceutical research 15, 698-705, 1998 | 1161 | 1998 |
| Simulated biological fluids with possible application in dissolution testing MRC Marques, R Loebenberg, M Almukainzi Dissolution Technol 18 (3), 15-28, 2011 | 1155 | 2011 |
| Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards R Löbenberg, GL Amidon European journal of pharmaceutics and biopharmaceutics 50 (1), 3-12, 2000 | 1080 | 2000 |
| Targeted delivery of nanoparticles for the treatment of lung diseases S Azarmi, WH Roa, R Löbenberg Advanced drug delivery reviews 60 (8), 863-875, 2008 | 561 | 2008 |
| Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung JOH Sham, Y Zhang, WH Finlay, WH Roa, R Löbenberg International journal of pharmaceutics 269 (2), 457-467, 2004 | 396 | 2004 |
| Current perspectives in dissolution testing of conventional and novel dosage forms S Azarmi, W Roa, R Löbenberg International Journal of pharmaceutics 328 (1), 12-21, 2007 | 389 | 2007 |
| Interaction of poly (butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro RN Alyaudtin, A Reichel, R Löbenberg, P Ramge, J Kreuter, DJ Begley Journal of drug targeting 9 (3), 209-221, 2001 | 255 | 2001 |
| Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells D Abrams, Y Huang, S McQuarrie, W Roa, H Chen, R Löbenberg, ... | 242 | 2006 |
| Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model WH Roa, S Azarmi, MHDK Al-Hallak, WH Finlay, AM Magliocco, ... Journal of Controlled Release 150 (1), 49-55, 2011 | 227 | 2011 |
| Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles S Azarmi, X Tao, H Chen, Z Wang, WH Finlay, R Löbenberg, WH Roa International journal of pharmaceutics 319 (1-2), 155-161, 2006 | 219 | 2006 |
| Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly (d, l-lactide-co-glycolic acid) and polyalkylcyanoacrylate P Lai, W Daear, R Löbenberg, EJ Prenner Colloids and Surfaces B: Biointerfaces 118, 154-163, 2014 | 209 | 2014 |
| Biorelevant dissolution media as a predictive tool for glyburide a class II drug H Wei, R Löbenberg European journal of pharmaceutical sciences 29 (1), 45-52, 2006 | 196 | 2006 |
| Liposomal drug delivery: a versatile platform for challenging clinical applications A Madni, M Sarfraz, M Rehman, M Ahmad, N Akhtar, S Ahmad, N Tahir, ... Journal of Pharmacy & Pharmaceutical Sciences 17 (3), 401-426, 2014 | 192 | 2014 |
| Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit® E100 H Valizadeh, A Nokhodchi, N Qarakhani, P Zakeri‐Milani, S Azarmi, ... Drug development and industrial pharmacy 30 (3), 303-317, 2004 | 187 | 2004 |
| Influence of the surfactant concentration on the body distribution of nanoparticles L Araujo, R Löbenberg, J Kreuter Journal of drug targeting 6 (5), 373-385, 1999 | 175 | 1999 |
| Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide R Löbenberg, J Krämer, VP Shah, GL Amidon, JB Dressman Pharmaceutical research 17, 439-444, 2000 | 171 | 2000 |
| Dynamic Dissolution Testing To Establish In Vitro/In Vivo Correlations for Montelukast Sodium, a Poorly Soluble Drug A Okumu, M DiMaso, R Löbenberg Pharmaceutical research 25, 2778-2785, 2008 | 155 | 2008 |
| Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery—a review S Gill, R Löbenberg, T Ku, S Azarmi, W Roa, EJ Prenner Journal of Biomedical Nanotechnology 3 (2), 107-119, 2007 | 152 | 2007 |
| Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery LG Sweeney, Z Wang, R Loebenberg, JP Wong, CF Lange, WH Finlay International journal of pharmaceutics 305 (1-2), 180-185, 2005 | 152 | 2005 |
| Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after iv injection to rats R Löbenberg, L Araujo, H von Briesen, E Rodgers, J Kreuter Journal of controlled release 50 (1-3), 21-30, 1998 | 150 | 1998 |
Nadia Bou-ChacraProfessor Pharmaceutical TechnologyVerified email at usp.br
